2022 GRI Conference

The 2022 GRI Virtual Conference Presented by CureGRIN and GRIN Therapeutics is now over. Researchers shared promising new research from their labs. Industry outlined plans for expanded clinical trials. And CureGRIN shared our plans to invest up to $900,000 over the next few months in research projects that will bring us closer to treatments and cures. 

If you missed any sessions we’ve got you covered. 

Videos of the sessions are now live on YouTube in English, Spanish, French, German, Italian, Dutch, Portuguese, Polish, Norwegian, Russian, and Chinese. 

Here are some of the highlights: 

• Researchers from University of Toronto shared promising preliminary results of gene therapy treatments on mice with GRI Disorder in the Gene Therapy Keynote. 

• GRIN Therapeutics announced plans to expand their upcoming clinical trials to include patients with GRIN1 and GRIN2A along with GRIN2B, in the Welcome session and The Search for GRI Drugs. 

• Doctors and pharmacologists outlined the potentially helpful medicines found inside the GRI Medicine Cabinet. 

• GRIN and GRIA families shared their journey in Family Presentations. 

• Our team at CureGRIN broke down how we raise and spend our money and our plans for how we will invest up to $900,000 in research over the next few months in CureGRIN Progress and Plans. 

• Researchers and clinicians answered questions at the top of mind for caregivers in Ask Me Anything. 

Thanks to the generous support of our Sponsors: GRIN Therapeutics, Sage Therapeutics, Varient, Simons Searchlight and Autism BrainNet.